drugset / Trial / NCT02769481
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate the effect of bexagliflozin compared to glimepiride as an add-on therapy to metformin in lowering hemoglobin A1c (HbA1c) levels in subjects with type 2 diabetes mellitus (T2DM).
Timeline
- Start
- 2016-08-15
- Primary completion
- 2019-06-14
- Completion
- 2019-06-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bexagliflozin | Small molecule | 20 mg | — |
| Comparator | Glimepiride | Small molecule | 2 mg | — |
| Comparator | Glimepiride | Small molecule | 4 mg | — |
| Comparator | Glimepiride | Small molecule | 6 mg | — |